EP4233850

CHEMOCENTRYX
Application Number
EP23160271A
Filing Date
Nov 27, 2019
Status
Granted And Under Opposition
Aug 30, 2024
Grant Date
Oct 2, 2024
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP4233850B1 was granted to Chemocentryx on Oct 2, 2024 following the initial filing on Nov 27, 2019 under the application number EP23160271A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

LEK PHARMACEUTICALS DDJun 12, 2025ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents